-
61.Noble metal Raney catalysts and preparation of hydrogenated compounds therewith 失效
标题翻译: 贵金属阮内催化剂及其氢化化合物的制备公开(公告)号:US06018048A
公开(公告)日:2000-01-25
申请号:US989157
申请日:1997-12-11
申请人: Kouhei Morikawa , Shuuji Hirayama , Yoshimasa Ishimura , Yuseki Suyama , Tsutomu Nozawa , Hiroyuki Monzen , Motoo Miura , Kuniomi Marumo , Taketoshi Naito
发明人: Kouhei Morikawa , Shuuji Hirayama , Yoshimasa Ishimura , Yuseki Suyama , Tsutomu Nozawa , Hiroyuki Monzen , Motoo Miura , Kuniomi Marumo , Taketoshi Naito
IPC分类号: C07D251/04 , B01J25/00 , C07B61/00 , C07C5/10 , C07C29/19 , C07C29/20 , C07C31/13 , C07C31/27 , C07C35/21 , C07C51/36 , C07C51/367 , C07C61/09 , C07C67/31 , C07C209/48 , C07C209/72 , C07C211/46 , C07C211/50 , C07D211/02 , C07D215/02 , C07D217/02 , C07D237/30 , C07D239/74 , C07D241/42 , C07D295/02 , C07D475/00 , C07C5/02
CPC分类号: C07C29/20 , B01J25/00 , C07C209/48 , C07C51/36 , C07C51/367 , C07C67/31 , C07D211/02 , C07C2101/14 , C07C2102/28
摘要: Noble metal, particularly ruthenium, Raney catalysts having the property of catalyzing the hydrogenation of (1) aromaticity-exhibiting ring portions of organic compounds, (2) carboxylic acids and their ester portions (carbonyl ester groups), (3) ring portions and carboxylic acid or their ester groups in compounds having such ring portions and carboxylic acid or their ester portions, and (4) ring portions and nitrile groups of aromatic nitrile compounds and methods for the preparation of corresponding hydrogenated compounds. The methods allow preparation of hydrogenated compounds having hydrogenated aromatic ring portions, hydrogenated carbonyl ester groups, hydrogenated aromatic ring and carbonyl ester groups, or hydrogenated aromatic rings and nitrile groups under milder hydrogen pressure and temperature conditions than the conventional catalysts.
摘要翻译: 贵金属,特别是钌,具有催化(1)有机化合物的芳香性显示环部分的氢化的性质的阮内催化剂,(2)羧酸及其酯部分(羰基酯基),(3)环部分和羧基 酸或其酯基,以及(4)芳族腈化合物的环部分和腈基以及制备相应的氢化化合物的方法。 该方法允许在比常规催化剂更温和的氢气压力和温度条件下,制备具有氢化芳环部分,氢化羰基酯基,氢化芳环和羰基酯基,或氢化芳环和腈基的氢化化合物。
-
62.Heterocyclic compounds having antidiabetic hypolipidemic antihypertensive properties process for their preparation and pharmaceutical compositions containing them 失效
标题翻译: 具有抗糖尿病降血脂降压特性的杂环化合物的制备方法和含有它们的药物组合物公开(公告)号:US6011036A
公开(公告)日:2000-01-04
申请号:US982962
申请日:1997-12-02
申请人: Vidya Bhushan Lohray , Braj Bhushan Lohray , Ranga Madhavan Gurram , Rajagopalan Ramanujam , Ranjan Chakrabarti
发明人: Vidya Bhushan Lohray , Braj Bhushan Lohray , Ranga Madhavan Gurram , Rajagopalan Ramanujam , Ranjan Chakrabarti
IPC分类号: C07D265/22 , C07D277/20 , C07D277/34 , C07D413/12 , C07D417/12 , A61K31/50 , A61K31/535 , C07D237/30 , C07D265/02
CPC分类号: C07D417/12 , C07D265/22 , C07D277/20 , C07D277/34 , C07D413/12
摘要: The present invention relates to novel antidiabetic compounds, their tautomeric forms, their analogues, their derivatives, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. This invention particularly relates to novel azolidinedione compounds of the general formula (I), and their analogues, their derivatives, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutical compositions containing them. ##STR1##
摘要翻译: 本发明涉及新型抗糖尿病化合物,其互变异构形式,其类似物,其衍生物,其立体异构体,其多晶型物,其药学上可接受的盐,其药学上可接受的溶剂化物和含有它们的药学上可接受的组合物。 本发明特别涉及通式(I)的新的唑烷二酮化合物及其类似物,其衍生物,其互变异构形式,其立体异构体,其多晶型物,其药学上可接受的盐,药学上可接受的溶剂化物和含有它们的药物组合物。
-
公开(公告)号:US5952359A
公开(公告)日:1999-09-14
申请号:US887858
申请日:1997-07-03
申请人: Christopher Richard Ayles Godfrey , Matthew Brian Hotson , Nan Catherine Sillars , Alan John Dowling , Michael Drysdale Turnbull , Harjinder Singh Bansal , Allison Mary Smith , Roger Salmon , Steven Fitzjohn
发明人: Christopher Richard Ayles Godfrey , Matthew Brian Hotson , Nan Catherine Sillars , Alan John Dowling , Michael Drysdale Turnbull , Harjinder Singh Bansal , Allison Mary Smith , Roger Salmon , Steven Fitzjohn
IPC分类号: A01N33/22 , A01N41/10 , A01N43/06 , A01N43/08 , A01N43/10 , A01N43/40 , A01N43/50 , A01N43/54 , A01N43/56 , A01N43/58 , A01N43/60 , A01N43/64 , A01N43/66 , A01N43/707 , A01N43/713 , A01N43/74 , A01N43/76 , A01N43/80 , A01N43/82 , A01N43/824 , A01N43/836 , A01P5/00 , A01P7/02 , A01P7/04 , C07C17/087 , C07C17/23 , C07C317/14 , C07C323/05 , C07C323/09 , C07D213/70 , C07D213/71 , C07D213/80 , C07D213/81 , C07D213/82 , C07D213/84 , C07D213/85 , C07D231/18 , C07D231/28 , C07D231/30 , C07D233/84 , C07D233/86 , C07D233/90 , C07D233/92 , C07D237/10 , C07D237/18 , C07D237/30 , C07D241/12 , C07D241/18 , C07D241/44 , C07D251/22 , C07D253/04 , C07D253/06 , C07D253/07 , C07D253/075 , C07D253/10 , C07D257/04 , C07D261/10 , C07D261/14 , C07D261/18 , C07D263/34 , C07D263/46 , C07D271/06 , C07D271/07 , C07D271/10 , C07D271/113 , C07D275/02 , C07D275/03 , C07D277/20 , C07D277/36 , C07D277/40 , C07D277/56 , C07D277/58 , C07D285/08 , C07D285/12 , C07D285/125 , C07D285/135 , C07D307/64 , C07D333/34 , C07D333/36 , C07D333/38 , C07D333/62 , C07D409/04 , C07D413/04 , C07D417/04 , C07D471/04 , A61K31/425
CPC分类号: C07D213/70 , A01N33/22 , A01N43/08 , A01N43/10 , A01N43/40 , A01N43/50 , A01N43/54 , A01N43/56 , A01N43/58 , A01N43/64 , A01N43/66 , A01N43/707 , A01N43/713 , A01N43/74 , A01N43/80 , A01N43/82 , C07C17/087 , C07C17/23 , C07C323/09 , C07D213/71 , C07D213/80 , C07D213/82 , C07D213/85 , C07D231/18 , C07D231/28 , C07D231/30 , C07D233/86 , C07D233/90 , C07D233/92 , C07D237/18 , C07D237/30 , C07D241/18 , C07D241/44 , C07D251/22 , C07D253/04 , C07D253/07 , C07D253/075 , C07D253/10 , C07D257/04 , C07D261/10 , C07D261/18 , C07D263/34 , C07D263/46 , C07D271/07 , C07D271/113 , C07D275/03 , C07D277/36 , C07D277/56 , C07D277/58 , C07D285/08 , C07D285/125 , C07D285/135 , C07D307/64 , C07D333/34 , C07D333/38 , C07D333/62 , C07D409/04 , C07D413/04 , C07D417/04 , C07D471/04
摘要: A compound of formula (I),R--S(O).sub.n CH.sub.2 CH.sub.2 CH.dbd.CF.sub.2or a salt thereof, wherein n is 0, 1 or 2; and R is a group of formula (V) or (VII) ##STR1## wherein: at least one of R.sup.2, R.sup.3, R.sup.4 or R.sup.5 is a S(O)nCH.sub.2 CH.sub.2 CH.dbd.CF.sub.2 group; and the remainder of R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are each independently hydrogen, optionally substituted alkyl, optionally substituted alkenyl, alkynyl, cycloalkyl, alkylcycloalkyl, alkoxy, alkenyloxy, alkynyloxy, hydroxyalkyl, alkoxyalkyl, optionally substituted aryl, optionally substituted arylalkyl, optionally substituted heteroaryl, optionally substituted heteroarylalkyl, optionally substituted aryloxy, optionally substituted arylalkoxy, optionally substituted aryloxyalkyl, optionally substituted heteroaryloxy, optionally substituted heteroarylalkoxy, optionally substituted heteroaryloxyalkyl, haloalkyl, haloalkenyl, haloalkynyl, haloalkoxy, haloalkenyloxy, haloalkynyloxy, halogen, hydroxy, cyano, nitro, --NR.sup.7 R.sup.8, --NR.sup.7 COR.sup.8, --NR.sup.7 CSR.sup.8, --NR.sup.7 SO.sub.2 R.sup.8, --NR.sup.7 SO.sub.2 R.sup.8, --N(SO.sub.2 R.sup.7)(SO.sub.2 R.sup.8), --COR.sup.7, --CONR.sup.7 R.sup.8, -alkylCONR.sup.7 R.sup.8, --CR.sup.7 NR.sup.8, --COR.sup.7, --OCOR.sup.7, --SR.sup.7, --SOR.sup.7, --SO.sub.2 R.sup.7, -alkylSR.sup.7, -alkylSOR.sup.7, -alkylSO.sub.2 R.sup.7, --OSO.sub.2 R.sup.7, --SO.sub.2 NR.sup.7 R.sup.8, --CSNR.sup.7 R.sup.8, --CSNR.sup.7 R.sup.8, --SiR.sup.7 R.sup.8 R.sup.9, --OCH.sub.2 CO.sub.2 R.sup.7, --OCH.sub.2 CH.sub.2 SO.sub.2 R.sup.7, --CONR.sup.7 SO.sub.2 R.sup.8, -alkylCONR.sup.7 SO.sub.2 R.sup.8, --NHCONR.sup.7 R.sup.8, --NHCSNR.sup.7 R.sup.8 ; and R.sup.7, R.sup.8 and R.sup.9 are each independently hydrogen, optionally substituted alkyl, optionally substituted alkenyl, alkynyl, optionally substituted aryl or optionally substituted arylalkyl, haloalkyl, haloalkenyl, haloalkynyl, halogen, or hydroxy; and agricultural compositions, and processes for preparing agricultural compositions made thereby.
摘要翻译: 式(I)化合物,R-S(O)nCH 2 CH 2 CH = CF 2或其盐,其中n为0,1或2; 并且R是式(V)或(VII)的基团,其中:R 2,R 3,R 4或R 5中的至少一个是S(O)n CH 2 CH 2 CH = CF 2基团; R 2,R 3,R 4和R 5的其余部分各自独立地为氢,任选取代的烷基,任选取代的烯基,炔基,环烷基,烷基环烷基,烷氧基,烯氧基,炔氧基,羟基烷基,烷氧基烷基,任选取代的芳基,任选取代的芳基烷基, 杂芳基,任选取代的杂芳基烷基,任选取代的芳氧基,任选取代的芳基烷氧基,任选取代的芳氧基烷基,任选取代的杂芳氧基,任选取代的杂芳基烷氧基,任选取代的杂芳基烷基,卤代烷基,卤代烯基,卤代炔基,卤代烷氧基,卤代烯氧基,卤代炔氧基,卤素,羟基,氰基,硝基, -NR7R8,-NR7COR8,-NR7CSR8,-NR7SO2R8,-NR7SO2R8,-N(SO2R7)(SO2R8),-COR7,-CONR7R8, - 烷基CONR7R8,-CR7NR8,-COR7,-OCOR7,-SR7,-SOR7,-SO2R7 , - 烷基-SR7, - 烷基-SOR7, - 烷基SO2R7,-OSO2R7,-SO2NR7R8,-CSNR7R8,-CSNR7R8,-SiR7R8R9,-OCH2CO2R7,-OCH2CH2SO2R7,-CONR7SO2R8, - 烷基CONR7SO2R8,-N HCONR7R8,-NHCSNR7R8; 任选取代的烯基,炔基,任选取代的芳基或任选取代的芳基烷基,卤代烷基,卤代烯基,卤代炔基,卤素或羟基; R 7,R 8和R 9各自独立地为氢,任选取代的烷基, 农业组合物,以及由此制备农业组合物的方法。
-
64.
公开(公告)号:US5942511A
公开(公告)日:1999-08-24
申请号:US098275
申请日:1998-06-16
申请人: Soon Kyoung Kwon , Sang Geon Kim , Young Nam Park , Mi Kyung Kim , Sung Hee Choi , Hea Soon Shin
发明人: Soon Kyoung Kwon , Sang Geon Kim , Young Nam Park , Mi Kyung Kim , Sung Hee Choi , Hea Soon Shin
IPC分类号: A61K31/495 , A61K31/50 , A61P1/16 , A61P43/00 , C07D237/18 , C07D237/30 , C07D237/32
CPC分类号: C07D237/18
摘要: The, present invention relates to a novel allylthiopyridazine derivative represented by formula (I) which exhibits a superior effect for prevention and treatment or hepatic diseases induced by toxic substances and for protection of human tissues from radiation: ##STR1## or a pharmaceutically acceptable salt thereof, in which R.sub.1 represents halogen atom, lower alkoxy, dialkylaminoalkoxy, hydroxyalkoxy, phenoxy substituted or unsubstituted with lower alkyl, benzyloxy, or phenyl, andR.sub.2 and R.sub.3 independently of one another represent hydrogen or lower alkyl, or R.sub.2 and R.sub.3 together with carbon atom to which they are attached can form a saturated or unsaturated 6-membered ring,provided that R.sub.2 and R.sub.3 are other than hydrogen when R.sub.1 is chloro; and to a process for preparing thereof and a pharmaceutical composition containing the same as an effective component.
摘要翻译: 本发明涉及一种由式(I)表示的新颖的烯丙基硫代哒嗪衍生物,其具有优异的预防和治疗效果或由有毒物质引起的肝脏疾病和用于保护人体组织免受辐射的效果:或其药学上可接受的盐,其中 R 1表示卤素原子,低级烷氧基,二烷基氨基烷氧基,羟基烷氧基,被低级烷基,苄氧基或苯基取代或未取代的苯氧基,R2和R3彼此独立地表示氢或低级烷基,或R2和R3与它们 连接时可以形成饱和或不饱和的6元环,条件是当R 1为氯时,R 2和R 3不是氢; 以及其制备方法和含有该组合物的药物组合物作为有效成分。
-
公开(公告)号:US5942504A
公开(公告)日:1999-08-24
申请号:US900733
申请日:1997-07-25
IPC分类号: A61K31/13 , A61K31/15 , A61K31/195 , A61K31/24 , A61K31/27 , A61K31/44 , A61K31/4402 , A61K31/4418 , A61K31/4427 , A61K31/47 , A61K31/50 , A61P31/12 , A61P31/18 , A61P37/04 , C07C243/12 , C07C243/14 , C07C243/26 , C07C243/28 , C07C271/20 , C07C281/02 , C07C323/23 , C07C323/60 , C07D213/24 , C07D213/30 , C07D213/81 , C07D215/12 , C07D215/48 , C07D231/54 , C07D237/04 , C07D237/08 , C07D237/26 , C07D237/30 , C07D401/12
CPC分类号: C07D215/48 , C07C271/20 , C07C281/02 , C07C323/60 , C07D213/30 , C07D213/81 , C07D231/54 , C07D237/04 , C07D237/30 , C07D401/12 , C07C2101/14
摘要: The present invention discloses the compounds of general formula (1) ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 are optionally substituted carbonyl and amide derivatives which are useful as inhibitors of retroviral proteases, and are effective in treating conditions characterized by unwanted activity of these enzymes, such as acquired immune deficiency syndrome.
摘要翻译: 本发明公开了通式(1)的化合物,其中R 1,R 2,R 3为任选取代的羰基和酰胺衍生物,其可用作逆转录病毒蛋白酶的抑制剂,并且有效治疗以这些酶为不期望的活性为特征的病症,例如 获得性免疫缺陷综合征。
-
公开(公告)号:US5912243A
公开(公告)日:1999-06-15
申请号:US702623
申请日:1996-08-28
申请人: Alan John Dowling , Alison Mary Craig , Christopher Richard Ayles Godfrey , Harjinder Singh Bansal , Matthew Brian Hotson , Michael Drysdale Turnbull , Nan Catherine Sillars , Roger Salmon , Steven Fitzjohn
发明人: Alan John Dowling , Alison Mary Craig , Christopher Richard Ayles Godfrey , Harjinder Singh Bansal , Matthew Brian Hotson , Michael Drysdale Turnbull , Nan Catherine Sillars , Roger Salmon , Steven Fitzjohn
IPC分类号: A01N33/22 , A01N41/10 , A01N43/06 , A01N43/08 , A01N43/10 , A01N43/40 , A01N43/50 , A01N43/54 , A01N43/56 , A01N43/58 , A01N43/60 , A01N43/64 , A01N43/66 , A01N43/707 , A01N43/713 , A01N43/74 , A01N43/76 , A01N43/80 , A01N43/82 , A01N43/824 , A01N43/836 , A01P5/00 , A01P7/02 , A01P7/04 , C07C17/087 , C07C17/23 , C07C317/14 , C07C323/05 , C07C323/09 , C07D213/70 , C07D213/71 , C07D213/80 , C07D213/81 , C07D213/82 , C07D213/84 , C07D213/85 , C07D231/18 , C07D231/28 , C07D231/30 , C07D233/84 , C07D233/86 , C07D233/90 , C07D233/92 , C07D237/10 , C07D237/18 , C07D237/30 , C07D241/12 , C07D241/18 , C07D241/44 , C07D251/22 , C07D253/04 , C07D253/06 , C07D253/07 , C07D253/075 , C07D253/10 , C07D257/04 , C07D261/10 , C07D261/14 , C07D261/18 , C07D263/34 , C07D263/46 , C07D271/06 , C07D271/07 , C07D271/10 , C07D271/113 , C07D275/02 , C07D275/03 , C07D277/20 , C07D277/36 , C07D277/40 , C07D277/56 , C07D277/58 , C07D285/08 , C07D285/12 , C07D285/125 , C07D285/135 , C07D307/64 , C07D333/34 , C07D333/36 , C07D333/38 , C07D333/62 , C07D409/04 , C07D413/04 , C07D417/04 , C07D471/04 , C04B35/52 , C07D251/00 , C07D253/00
CPC分类号: C07D213/70 , A01N33/22 , A01N43/08 , A01N43/10 , A01N43/40 , A01N43/50 , A01N43/54 , A01N43/56 , A01N43/58 , A01N43/64 , A01N43/66 , A01N43/707 , A01N43/713 , A01N43/74 , A01N43/80 , A01N43/82 , C07C17/087 , C07C17/23 , C07C323/09 , C07D213/71 , C07D213/80 , C07D213/82 , C07D213/85 , C07D231/18 , C07D231/28 , C07D231/30 , C07D233/86 , C07D233/90 , C07D233/92 , C07D237/18 , C07D237/30 , C07D241/18 , C07D241/44 , C07D251/22 , C07D253/04 , C07D253/07 , C07D253/075 , C07D253/10 , C07D257/04 , C07D261/10 , C07D261/18 , C07D263/34 , C07D263/46 , C07D271/07 , C07D271/113 , C07D275/03 , C07D277/36 , C07D277/56 , C07D277/58 , C07D285/08 , C07D285/125 , C07D285/135 , C07D307/64 , C07D333/34 , C07D333/38 , C07D333/62 , C07D409/04 , C07D413/04 , C07D417/04 , C07D471/04
摘要: A compound having the formula R--S(O).sub.n CH.sub.2 CH.sub.2 CH.dbd.CF.sub.2, or a salt thereof, wherein R is a phenyl group or a heterocyclic group selected from furyl, thienyl, isoxazolyl, isothiazolyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, 1,2,4-oxadiazolyl, 1,2,4-thiadiazolyl, 1,3,4-oxadiazolyl, 1,3,4-thiadiazolyl, tetrazolyl, pyridyl, pyridazinyl, pyrazinyl, 1,2,3-triazinyl, 1,3,4-triazinyl and 1,3,5-triazinyl groups, said phenyl or heterocyclic group being optionally substituted by optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, cycloalkyl, alkylcycloalkyl, alkoxy, alkenyloxy, alkynyloxy, hydroxyalkyl, alkoxyalkyl, optionally substituted aryl, optionally substituted arylalkyl, optionally substituted heteroaryl, optionally substituted heteroarylalkyl, optionally substituted aryloxy, optionally substituted arylalkoxy, optionally substituted aryloxyalkyl, optionally substituted heteroaryloxy, optionally substituted heteroarylalkoxy, optionally substituted heteroaryloxyalkyl, haloalkyl, haloalkenyl, haloalkynyl, haloalkoxy, haloalkenyloxy, haloalkynyloxy, halogen, hydroxy, cyano, nitro, --NR7R8, --NR7COR8, --NR7CSR8, --NR7SO2R8, --N(SO2R7)(SO2R8), --COR7, --CONR7R8, -alkylCONR7R8, --CR7NR8, --COOR7, --OCOR7, --SR7, --SOR7, --SO2R7, -alkylSR7, -alkylSOR7, -alkylSO2R7, --OSO2R7, --SO2NR7R8, --CSNR7R8, --SiR7R8R9, --OCH2CO2R7, --OCH2CH2CO2R7, --CONR7SO2R8, -alkylCONR7SO2R8, --NHCONR7R8, --NHCSNR7R8, or an adjacent pair of R1, R2, R3, R4, R5 and R6 when taken together form a fused 5- or 6-membered carbocyclic or heterocyclic ring; and R7, R8 and R9 are each independently hydrogen, optionally substituted alkyl, optionally substituted alkenyl, alkynyl, optionally substituted aryl or optionally substituted arylalkyl, haloalkyl, haloalkenyl, haloalkynyl, halogen, or hydroxy.
-
公开(公告)号:US5744610A
公开(公告)日:1998-04-28
申请号:US683727
申请日:1996-07-18
申请人: John E. D. Barton , David Cartwright , John M. Cox , Glynn Mitchell , Charles G. Carter , David L. Lee , Francis H. Walker , Frank X. Woolard
发明人: John E. D. Barton , David Cartwright , John M. Cox , Glynn Mitchell , Charles G. Carter , David L. Lee , Francis H. Walker , Frank X. Woolard
IPC分类号: A01N35/06 , A01N37/08 , A01N43/08 , A01N43/10 , A01N43/12 , A01N43/30 , A01N43/32 , A01N43/36 , A01N43/38 , A01N43/40 , A01N43/42 , A01N43/50 , A01N43/56 , A01N43/58 , A01N43/60 , A01N43/76 , A01N43/78 , A01N43/80 , A01N43/92 , A47J37/12 , C07C45/51 , C07C45/54 , C07C45/60 , C07C45/67 , C07C45/72 , C07C49/403 , C07C49/713 , C07C49/792 , C07C49/813 , C07C49/835 , C07D207/32 , C07D207/333 , C07D207/34 , C07D207/36 , C07D209/12 , C07D215/12 , C07D215/14 , C07D215/36 , C07D231/12 , C07D231/16 , C07D231/20 , C07D231/22 , C07D233/84 , C07D237/12 , C07D237/28 , C07D237/30 , C07D239/26 , C07D239/74 , C07D241/12 , C07D241/16 , C07D241/42 , C07D261/08 , C07D263/54 , C07D263/56 , C07D277/20 , C07D277/24 , C07D277/32 , C07D277/36 , C07D307/70 , C07D307/71 , C07D317/52 , C07D317/62 , C07D319/08 , C07D319/18 , C07D333/22 , C07D333/28 , C07D333/62 , C07D409/04 , C07D417/04 , C07F9/6568 , G05D23/20
CPC分类号: C07D207/333 , A01N35/06 , A01N37/08 , A01N43/08 , A01N43/10 , A01N43/30 , A01N43/32 , A01N43/36 , A01N43/38 , A01N43/40 , A01N43/42 , A01N43/50 , A01N43/56 , A01N43/58 , A01N43/60 , A01N43/78 , A01N43/80 , A47J37/1266 , C07C45/512 , C07C45/54 , C07C45/60 , C07C45/673 , C07C45/72 , C07C49/403 , C07C49/713 , C07C49/792 , C07C49/813 , C07C49/835 , C07D207/36 , C07D209/12 , C07D215/14 , C07D215/36 , C07D231/12 , C07D231/16 , C07D233/84 , C07D237/12 , C07D241/12 , C07D241/16 , C07D241/42 , C07D261/08 , C07D263/56 , C07D277/24 , C07D277/32 , C07D277/36 , C07D307/70 , C07D307/71 , C07D317/52 , C07D317/62 , C07D319/08 , C07D319/18 , C07D333/22 , C07D333/28 , C07D333/62 , C07D409/04 , C07D417/04 , C07F9/6568 , G05D23/1917 , G05D23/20
摘要: A compound of formula (I): ##STR1## or a salt, enamine or the like, acylate, sulphonate, carbamate or ether derivative thereof; wherein X, X.sup.1 and X.sup.2 are independently oxygen or sulphur, R.sup.1 is an optionally substituted heterocyclic or cycloalkyl group, and Y is an optionally substituted C.sub.2 -C.sub.4 alkylene group which is optionally interposed, by an oxygen atom, a group ##STR2## a group ##STR3## or an optionally mono-substituted nitrogen atom, wherein p is 0, 1 or 2, s is 0 or 1 and R.sup.b is alkyl or alkoxy; provided that when X, X.sup.1 and X.sup.2 are oxygen, R.sup.1 is not pyridyl or pyrimidinyl. Processes for the preparation of these compounds and herbicidal compositions containing them are also described and claimed.
摘要翻译: 式(I)的化合物:其中,酰化物,磺酸盐,氨基甲酸酯或醚衍生物;或其盐,烯胺等; 其中X,X 1和X 2独立地是氧或硫,R 1是任选取代的杂环或环烷基,Y是任选被取代的C 2 -C 4亚烷基,其任选被氧原子插入基团 或者任选单取代的氮原子,其中p为0,1或2,s为0或1,Rb为烷基或烷氧基; 条件是当X,X 1和X 2是氧时,R 1不是吡啶基或嘧啶基。 还描述和要求保护这些化合物和含有它们的除草组合物的制备方法。
-
68.Quinaldoyl-amine derivatives of oxo-and hydroxy-substituted hydrocarbons 失效
标题翻译: 氧代 - 和羟基取代的烃的喹喔啉胺衍生物公开(公告)号:US5679688A
公开(公告)日:1997-10-21
申请号:US295855
申请日:1994-11-04
IPC分类号: A61K31/13 , A61K31/15 , A61K31/195 , A61K31/24 , A61K31/27 , A61K31/44 , A61K31/4402 , A61K31/4418 , A61K31/4427 , A61K31/47 , A61K31/50 , A61P31/12 , A61P31/18 , A61P37/04 , C07C243/12 , C07C243/14 , C07C243/26 , C07C243/28 , C07C271/20 , C07C281/02 , C07C323/23 , C07C323/60 , C07D213/24 , C07D213/30 , C07D213/81 , C07D215/12 , C07D215/48 , C07D231/54 , C07D237/04 , C07D237/08 , C07D237/26 , C07D237/30 , C07D401/12 , C07D215/14
CPC分类号: C07D215/48 , C07C271/20 , C07C281/02 , C07C323/60 , C07D213/30 , C07D213/81 , C07D231/54 , C07D237/04 , C07D237/30 , C07D401/12 , C07C2101/14
摘要: The present invention discloses the compounds of general formula (1) ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 are optionally substituted carbonyl and amide derivatives which are useful as inhibitors of retroviral proteases, and are effective in treating conditions characterized by unwanted activity of these enzymes, such as acquired immune deficiency syndrome.
摘要翻译: PCT No.PCT / AU93 / 00103 Sec。 371日期:1994年11月4日 102(e)日期1994年11月4日PCT 1993年3月11日PCT公布。 公开号WO93 / 18006 日本1993年9月16日本发明公开了通式(1)的化合物,其中R 1,R 2,R 3为任选取代的羰基和酰胺衍生物,其可用作逆转录病毒蛋白酶的抑制剂, 这些酶的不期望的活性,如获得性免疫缺陷综合征。
-
公开(公告)号:US5563115A
公开(公告)日:1996-10-08
申请号:US453916
申请日:1995-05-30
申请人: John E. D. Barton , David Cartwright , John M. Cox , Glynn Mitchell , Charles G. Carter , David L. Lee , Francis H. Walker , Frank X. Woolard
发明人: John E. D. Barton , David Cartwright , John M. Cox , Glynn Mitchell , Charles G. Carter , David L. Lee , Francis H. Walker , Frank X. Woolard
IPC分类号: A01N35/06 , A01N37/08 , A01N43/08 , A01N43/10 , A01N43/12 , A01N43/30 , A01N43/32 , A01N43/36 , A01N43/38 , A01N43/40 , A01N43/42 , A01N43/50 , A01N43/56 , A01N43/58 , A01N43/60 , A01N43/76 , A01N43/78 , A01N43/80 , A01N43/92 , A47J37/12 , C07C45/51 , C07C45/54 , C07C45/60 , C07C45/67 , C07C45/72 , C07C49/403 , C07C49/713 , C07C49/792 , C07C49/813 , C07C49/835 , C07D207/32 , C07D207/333 , C07D207/34 , C07D207/36 , C07D209/12 , C07D215/12 , C07D215/14 , C07D215/36 , C07D231/12 , C07D231/16 , C07D231/20 , C07D231/22 , C07D233/84 , C07D237/12 , C07D237/28 , C07D237/30 , C07D239/26 , C07D239/74 , C07D241/12 , C07D241/16 , C07D241/42 , C07D261/08 , C07D263/54 , C07D263/56 , C07D277/20 , C07D277/24 , C07D277/32 , C07D277/36 , C07D307/70 , C07D307/71 , C07D317/52 , C07D317/62 , C07D319/08 , C07D319/18 , C07D333/22 , C07D333/28 , C07D333/62 , C07D409/04 , C07D417/04 , C07F9/6568 , G05D23/20 , C07D401/04 , A01N43/72 , C07D405/04 , C07D409/14
CPC分类号: C07D207/333 , A01N35/06 , A01N37/08 , A01N43/08 , A01N43/10 , A01N43/30 , A01N43/32 , A01N43/36 , A01N43/38 , A01N43/40 , A01N43/42 , A01N43/50 , A01N43/56 , A01N43/58 , A01N43/60 , A01N43/78 , A01N43/80 , A47J37/1266 , C07C45/512 , C07C45/54 , C07C45/60 , C07C45/673 , C07C45/72 , C07C49/403 , C07C49/713 , C07C49/792 , C07C49/813 , C07C49/835 , C07D207/36 , C07D209/12 , C07D215/14 , C07D215/36 , C07D231/12 , C07D231/16 , C07D233/84 , C07D237/12 , C07D241/12 , C07D241/16 , C07D241/42 , C07D261/08 , C07D263/56 , C07D277/24 , C07D277/32 , C07D277/36 , C07D307/70 , C07D307/71 , C07D317/52 , C07D317/62 , C07D319/08 , C07D319/18 , C07D333/22 , C07D333/28 , C07D333/62 , C07D409/04 , C07D417/04 , C07F9/6568 , G05D23/1917 , G05D23/20
摘要: A compound of formula (I): ##STR1## or a salt, enamine or the like, acylate, sulphonate, carbamate or ether derivative thereof; wherein X, X.sup.1 and X.sup.2 are independently oxygen or sulphur, R.sup.1 is an optionally substituted heterocyclic or cycloalkyl group, and Y is an optionally substituted C.sub.2 -C.sub.4 alkylene group which is optionally interposed by an oxygen atom, a group ##STR2## a group ##STR3## or an optionally mono-substituted nitrogen atom, wherein p is 0, 1 or 2, s is 0 or 1 and R.sup.b is alkyl or alkoxy; provided that when X, X.sup.1 and X.sup.2 are oxygen, R.sup.1 is not pyridyl or pyrimidinyl. Processes for the preparation of these compounds and herbicidal compositions containing them are also described and claimed.
-
公开(公告)号:US5114940A
公开(公告)日:1992-05-19
申请号:US355976
申请日:1989-05-22
IPC分类号: A01N43/42 , A01N43/54 , A01N43/58 , A01N43/60 , A01N43/78 , A01N49/00 , C07D215/14 , C07D215/20 , C07D215/22 , C07D215/227 , C07D215/233 , C07D215/26 , C07D215/28 , C07D215/36 , C07D215/54 , C07D217/16 , C07D217/22 , C07D217/24 , C07D237/28 , C07D237/30 , C07D239/88 , C07D239/95 , C07D241/44 , C07D277/68 , C07D405/12
CPC分类号: C07D215/227 , A01N43/42 , A01N49/00 , C07D215/14 , C07D215/20 , C07D215/22 , C07D215/233 , C07D215/26 , C07D215/28 , C07D215/36 , C07D215/54 , C07D217/24 , C07D237/28 , C07D237/30 , C07D239/95 , C07D241/44 , C07D277/68
摘要: Compound of the formula (I) are disclosedArQQ.sup.1 C(.dbd.X)NHR.sup.1 (I)or a salt thereof, wherein Ar is an optionally substituted polycyclic ring system containing n rings, where n is the integer 2 or 3, at least n-1 rings being aromatic and containing one to three ring nitrogen atoms and optionally containing one or more additional heteroatoms; Q is an alkyl chain containing 1 to 12 carbon atoms and optionally containing a sulphur or one or two oxygen atoms; Q.sup.1 is a group (C(R.sup.2).dbd.C(R.sup.3)).sub.a --(C(R.sup.4).dbd.C(R.sup.5)) wherein a is 0 or 1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are the same or different, at least two being hydrogen and the other two being independently selected from hydrogen, halo, C.sub.1-4 haloalkyl; X is oxygen or sulphur; and R.sup.1 is selected from hydrogen and C.sub.1-8 hydrocarbyl optionally substituted by dioxalanyl, halo, cyano, trifluoromethyl, trifluoromethylthio or C.sub.1-6 alkoxy are described which have activity particularly against arthropod pests. Pesticidal formulations containing the compounds of the formula (1), their use in the control of pests and method for their preparation are also disclosed.
-
-
-
-
-
-
-
-
-